Showing 1 - 6 results of 6 for search 'Adrian H Batchelor', query time: 0.03s Refine Results
  1. 1
    Structure of the malaria antigen AMA1 in complex with a growth-inhibitory antibody.

    Structure of the malaria antigen AMA1 in complex with a growth-inhibitory antibody. by Andrew M Coley, Aditi Gupta, Vince J Murphy, Tao Bai, Hanna Kim, Michael Foley, Robin F Anders, Adrian H Batchelor

    Published 2007-09-01
    Get full text
    Article
  2. 2
    Correction: Structure of the Malaria Antigen AMA1 in Complex with a Growth-Inhibitory Antibody.

    Correction: Structure of the Malaria Antigen AMA1 in Complex with a Growth-Inhibitory Antibody. by Andrew M Coley, Aditi Gupta, Vince J Murphy, Tao Bai, Hanna Kim, Michael Foley, Robin F Anders, Adrian H Batchelor

    Published 2007-11-01
    Get full text
    Article
  3. 3
    High antibody titer against apical membrane antigen-1 is required to protect against malaria in the Aotus model.

    High antibody titer against apical membrane antigen-1 is required to protect against malaria in the Aotus model. by Sheetij Dutta, JoAnn S Sullivan, Katharine K Grady, J David Haynes, Jack Komisar, Adrian H Batchelor, Lorraine Soisson, Carter L Diggs, D Gray Heppner, David E Lanar, William E Collins, John W Barnwell

    Published 2009-12-01
    Get full text
    Article
  4. 4
    Restricted valency (NPNA) n repeats and junctional epitope-based circumsporozoite protein vaccines against Plasmodium falciparum

    Restricted valency (NPNA) n repeats and junctional epitope-based circumsporozoite protein vaccines against Plasmodium falciparum by Mark D. Langowski, Farhat A. Khan, Sofya Savransky, Dallas R. Brown, Arasu Balasubramaniyam, William B. Harrison, Xiaoyan Zou, Zoltan Beck, Gary R. Matyas, Jason A. Regules, Robin Miller, Lorraine A. Soisson, Adrian H. Batchelor, Sheetij Dutta

    Published 2022-01-01
    Get full text
    Article
  5. 5
    Overcoming antigenic diversity by enhancing the immunogenicity of conserved epitopes on the malaria vaccine candidate apical membrane antigen-1.

    Overcoming antigenic diversity by enhancing the immunogenicity of conserved epitopes on the malaria vaccine candidate apical membrane antigen-1. by Sheetij Dutta, Lisa S Dlugosz, Damien R Drew, Xiaopeng Ge, Diouf Ababacar, Yazmin I Rovira, J Kathleen Moch, Meng Shi, Carole A Long, Michael Foley, James G Beeson, Robin F Anders, Kazutoyo Miura, J David Haynes, Adrian H Batchelor

    Published 2013-01-01
    Get full text
    Article
  6. 6
    Unglycosylated Soluble SARS-CoV-2 Receptor Binding Domain (RBD) Produced in <i>E. coli</i> Combined with the Army Liposomal Formulation Containing QS21 (ALFQ) Elicits Neutralizing Antibodies against Mismatched Variants

    Unglycosylated Soluble SARS-CoV-2 Receptor Binding Domain (RBD) Produced in <i>E. coli</i> Combined with the Army Liposomal Formulation Containing QS21 (ALFQ) Elicits Neutralizing... by Arasu Balasubramaniyam, Emma Ryan, Dallas Brown, Therwa Hamza, William Harrison, Michael Gan, Rajeshwer S. Sankhala, Wei-Hung Chen, Elizabeth J. Martinez, Jaime L. Jensen, Vincent Dussupt, Letzibeth Mendez-Rivera, Sandra Mayer, Jocelyn King, Nelson L. Michael, Jason Regules, Shelly Krebs, Mangala Rao, Gary R. Matyas, M. Gordon Joyce, Adrian H. Batchelor, Gregory D. Gromowski, Sheetij Dutta

    Published 2022-12-01
    Get full text
    Article

Search Tools: